Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study.

ABSTRACT:

SUBMITTER: Li J 

PROVIDER: S-EPMC12369717 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature